In the arachidonic pathway and other pathways with the reactions controlled by the CYP proteins targeting breast cancer drugs, none or few reactions were differentially present in the natural product models, suggesting that these pathways were not targeted by natural product models (Supplementary File S2, Figure S8). Here, PPIG is linked to breast cancer.